OBio Inc. is a biopharmaceutical company established in Delaware, USA.
Committed to Bringing Novel Ophthalmic Medicines to Patients

We are a biopharmaceutical company focused on the discovery, development, and commercialization of novel ophthalmic therapies to address the unmet medical needs. Our mission is to bring novel ophthalmic therapies to patients in China and Southeast Asia for better efficacy.
Who We Are

We are a biopharmaceutical company focused on the discovery, development, and commercialization of novel ophthalmic therapies to address the unmet needs.
Learn More

Our Mission

We are committed to leveraging our unique platform to bring novel treatment options to eye disease patients in China and Southeast Asia.

Our Strategy

We seize the opportunities in the emerging ophthalmic medicine markets in China and Southeast Asia through our unique platform and global network.

Our Pipeline

We are establishing a differentiated ophthalmic medicine portfolio through our unparalleled innovation strategy.

Get Connected

If you’d like to get in touch with us, you can send a message here.

    • *Required field
    Sending...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
© 2025 OBio Inc. All Rights Reserved Cookie Policy